You Make the Call

You Make the Call

Each month we’ll pick a challenging clinical question submitted through the Consult-a-Colleague program and post the expert’s response.

You Make the Call

What is your approach to a patient who is referred for an immunofixation showing...

This month, Robert A. Kyle, MD, answers a question about the “faint monoclonal band” of IgG kappa or IgG lambda in a dense polyclonal...
You Make the Call

Should ATRA be held in a patient with acute promyelocytic leukemia and a high...

This month, Geoffrey L. Uy, MD, answers a question about white blood cell counts in a patient being treated for acute promyelocytic leukemia.A 52-year-old...
You Make the Call

Anticoagulation recommendations for a young patient who developed DVT after knee surgery, and then...

This month, Alice J. Cohen, MD, advises on the choice of anticoagulation in a patient who developed pulmonary embolism after knee surgery.A 28-year-old male...

When should I order gene studies to establish clonality and rule out B-cell lymphoproliferative...

This month, Carol S. Portlock, MD, advises on gene studies to establish clonality in B-cell lymphoproliferative disorders.I perform T-cell receptor gene studies to establish clonality...
You Make the Call

What should the duration of anticoagulation be for a patient with idiopathic renal infarct?

Clinical Dilemma:  David Garcia, MD: This month, David Garcia, MD, advises on the length of anticoagulation in a patient with an idiopathic renal infarct.I have a...
You Make the Call

How would you treat a patient with Hodgkin lymphoma and bleomycin lung injury?

This month, George P. Canellos, MD, advises on treatment options for a young patient with Hodgkin lymphoma and bleomycin lung injury.A 23-year-old male patient with...
You Make the Call

What options do I have for an elderly patient with Hodgkin lymphoma who cannot...

This month, John Sweetenham, MD, advises on treatment options for an elderly patient with Hodgkin lymphoma.I have a 90-year-old female patient with relatively poor performance...
You Make the Call

Should I have concerns about using an oral thrombin inhibitor in a patient with...

This month, Michael H. Kroll, MD, advises on switching a patient with a history of deep-vein thrombosis (DVT) from warfarin to an oral thrombin inhibitor.A...
You Make the Call

Is it reasonable to use rivaroxaban as an antithrombotic drug in obese patients?

This month, Kenneth A. Bauer, MD, advises on the use of target-specific oral anticoagulants in obese patients.Is it reasonable to use rivaroxaban as an antithrombotic...
You Make the Call

Is pegfilgrastim with ABVD in Hodgkin lymphoma necessary?

This month, Sonali M. Smith, MD, advises on the use of pegfilgrastim with ABVD for treating Hodgkin lymphoma. What is your opinion on the use...
Advertisement

Current Issue

October 2019, Volume 5, Issue 12

This issue highlights the unintended consequences of fighting the nation’s opioid epidemic, considers the optimal frontline regimen for myeloma, and more.